Navigation Links
Gene therapy potential for treatment of pancreatic cancer

A gene responsible for the production of a protein called vasostatin may prove a promising new way of treating pancreatic cancer, suggests research published ahead of print in Gut.

Pancreatic cancer is the fifth leading cause of cancer deaths in the developed world, and is extremely difficult to treat. Only 3% of affected patients are still alive five years after diagnosis, a survival rate that has remained static for the past three decades.

Currently, the only viable treatment is surgery. Radiotherapy and chemotherapy have little impact on the disease.

The research team investigated the potential of the protein vasostatin to suppress the development of new blood vessels and pancreatic tumour cells both in test tubes and in mice with pancreatic cancer.

'Solid' tumours, such as pancreatic cancer, are heavily dependent on a rich blood supply to enable them to grow rapidly and spread throughout the body. This process is known as angiogenesis.

The protein gene was incorporated into a virus (adenovirus), so that it would be able to penetrate the cells, acting as a vector.

The test tube experiments showed that 72 hours after infection with the genetically modified virus, vasostatin was clearly active in the tissue. Tumour growth in the mice was also curbed, and when compared with mice which had not been infected with the virus, the difference between the two groups was highly significant.

The researchers then looked more closely at the pancreatic cells and the cell linings of the blood vessels (vascular endothelial cells).

They found that although vasostatin seemed to have little impact on the pancreatic cells, it blocked the formation of new blood vessels, effectively cutting off the supply of nutrients to the malignant cells. This effect was seen in both the test tube and animal experiments.

This type of gene therapy "may be a potent strategy to treat many malignant tumours, including pancreatic can
'"/>

Source:BMJ Specialty Journals


Page: 1 2

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Columbia research lifts major hurdle to gene therapy for cancer
3. Combination therapy boosts effectiveness of telomere-directed cancer cell death
4. Gene therapy converts dead bone graft to new, living tissue
5. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
8. New therapy for HIV/AIDS eliminates needles and excessive toxicity
9. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
10. Gene therapy for Parkinsons disease moves forward in animals
11. Pulsating ultrasound enhances gene therapy for tumors
Post Your Comments:
(Date:12/13/2009)... have resolved a question about how a popular ... using biosensors that reveal previously hidden components of ... delusions and hallucinations characterize the illness, people with ... information in a particular order, difficulties that interfere ... function well, said Lee Schroeder, a student in ...
(Date:12/11/2009)... the global "green" trend, educators worldwide are ... enhance students, science knowledge. Studies have revealed ... raises not just science scoresenvironmental-based lessons can ... subject areas. Naturally, educators are interested in ... lessons into the classroom in hopes of ...
(Date:12/11/2009)... studying how bacteria under stress collectively weigh and initiate ... into how humans make strategic decisions that affect their ... , Their study, published this week in the early ... National Academy of Sciences , was accomplished when the ... describe the complex interplay of genes and proteins that ...
Breaking Biology News(10 mins):New biosensors reveal workings of anti-psychotic drugs in the living brain 2Students learn environmental stewardship, improve science scores 2Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5Women More Prone to Die in Month After Heart Attack 55329 1Women More Prone to Die in Month After Heart Attack 55329 2Women More Prone to Die in Month After Heart Attack 55329 3More Women Surviving After Early Breast Cancer 55327 1More Women Surviving After Early Breast Cancer 55327 2More Women Surviving After Early Breast Cancer 55327 3Standard 26amp 3B Poor 26apos 3Bs Upgrades Wellmont Outlook 55325 1Standard 26amp 3B Poor 26apos 3Bs Upgrades Wellmont Outlook 55325 2Standard 26amp 3B Poor 26apos 3Bs Upgrades Wellmont Outlook 55325 3
... & Children,s Hospital and the University of Adelaide, Australia, ... with high blood pressure during pregnancy and pre-term birth. ... of Obstetrics & Gynaecology, are a major step forward ... blood pressure in pregnancy. , The research has been ...
... balance of nature looms prominently in the public mind these ... declining fish stocks are but a few of the issues ... is it? , It depends on whom you ask, ... the School of Life Sciences specializing in biology and society. ...
... devastates Manhattan, but no group takes credit. The pressure ... on sketchy information, the president orders an attack, but ... the wrong country. Things go downhill from there. , ... of 12 scientists with extensive nuclear expertise, headed by ...
Other Biology News:Herpes virus link to complications in pregnancy 2Managing uncertainty important in ecological balance: ASU researcher 2Group led by Stanford physicist says there's an urgent need for nuclear detectives 2Group led by Stanford physicist says there's an urgent need for nuclear detectives 3
(Date:12/11/2009)... Biosciences Corporation announced today the enrollment and dosing at ... of the first patient in the ACE ( ... Phase 2 pivotal trial in patients with relapsed or ... novel, orally available, potent and highly selective small molecule ... (FLT3) inhibitor. The ACE study is designed to ...
(Date:12/11/2009)... -- Esco announces the opening of a NEW 2nd North American ... service, training and logistics center to support Esco,s growth in the ... (NPI) for temperature-controlled laboratory equipment. , ... Hatboro, PA ... NEW 2nd North American facility in Marietta, OH. The facility will ...
(Date:12/10/2009)... NEW YORK, Dec. 10 With the economy ... Company, Wall Street,s largest, fastest-growing small cap equity research ... of unique investment opportunities within the micro cap market ... on January 11, 2010 at the Grand Hyatt ... cap companies are overlooked and undervalued by much of ...
(Date:12/10/2009)... 10 Vivakor, Inc. (OTC Bulletin ... entered into an exclusive, $5 million license ... Inc. ( www.regeneca.com ). The agreement ... a new cutting-edge nutraceutical formulation developed by ... future formulations by Vivakor for Regeneca. Under ...
Breaking Biology Technology:Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3
... wondered why a,starfish can completely grow a new arm, ... salamander can regenerate a severed leg, but human beings,have ... have asked the same,questions for a long time and, ... find the answers. What,s even,more exciting is that much ...
... 8 Pharmaceutical Institute, a,subsidiary of Campbell Alliance, ... and biotech industry, today announced,the release of a ... dynamic market environment and offering key new insights ... new edition of "Understanding Pharma" analyzes nine key ...
... 8 RADI Medical Systems today,announced improvements ... PressureWire(R) Certus, which will begin shipments immediately., ... The latest generation of the PressureWire(R) Certus ... provides three key,advantages for physicians. The new ...
Other Biology Technology:Pittsburgh Region Middle School Students Participate in Hands-on Tissue Engineering Summer Camp 2Pittsburgh Region Middle School Students Participate in Hands-on Tissue Engineering Summer Camp 3Pharmaceutical Institute, in Collaboration With Campbell Alliance, Releases Second Edition of Breakthrough Book on the Inner Workings of the Pharmaceutical Industry 2Pharmaceutical Institute, in Collaboration With Campbell Alliance, Releases Second Edition of Breakthrough Book on the Inner Workings of the Pharmaceutical Industry 3Pharmaceutical Institute, in Collaboration With Campbell Alliance, Releases Second Edition of Breakthrough Book on the Inner Workings of the Pharmaceutical Industry 4Pharmaceutical Institute, in Collaboration With Campbell Alliance, Releases Second Edition of Breakthrough Book on the Inner Workings of the Pharmaceutical Industry 5RADI Medical Systems Launches Next Generation PressureWire(R) Certus 2
Rat monoclonal [HK5.3] to B7 RP1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 23308 SwissProtID: O75144...
Zinc finger MYM-type protein 3 (Zinc finger protein 261) (DXS6673E protein). [Source:Uniprot/SWISSPROT;Acc:Q14202] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Human Ig Lambda-chain, clone ICO-16, Monoclonal Antibody...
Phospho-FADD (Ser194) Antibody (Human Specific)...
Biology Products: